231 related articles for article (PubMed ID: 21172357)
1. Caveolin-1 negatively regulates a metalloprotease-dependent epidermal growth factor receptor transactivation by angiotensin II.
Takaguri A; Shirai H; Kimura K; Hinoki A; Eguchi K; Carlile-Klusacek M; Yang B; Rizzo V; Eguchi S
J Mol Cell Cardiol; 2011 Mar; 50(3):545-51. PubMed ID: 21172357
[TBL] [Abstract][Full Text] [Related]
2. ADAM17 mediates epidermal growth factor receptor transactivation and vascular smooth muscle cell hypertrophy induced by angiotensin II.
Ohtsu H; Dempsey PJ; Frank GD; Brailoiu E; Higuchi S; Suzuki H; Nakashima H; Eguchi K; Eguchi S
Arterioscler Thromb Vasc Biol; 2006 Sep; 26(9):e133-7. PubMed ID: 16840716
[TBL] [Abstract][Full Text] [Related]
3. Caveolin-1 is required for TGF-β-induced transactivation of the EGF receptor pathway in hepatocytes through the activation of the metalloprotease TACE/ADAM17.
Moreno-Càceres J; Caja L; Mainez J; Mayoral R; Martín-Sanz P; Moreno-Vicente R; Del Pozo MÁ; Dooley S; Egea G; Fabregat I
Cell Death Dis; 2014 Jul; 5(7):e1326. PubMed ID: 25032849
[TBL] [Abstract][Full Text] [Related]
4. Caveolin 1 is critical for abdominal aortic aneurysm formation induced by angiotensin II and inhibition of lysyl oxidase.
Takayanagi T; Crawford KJ; Kobayashi T; Obama T; Tsuji T; Elliott KJ; Hashimoto T; Rizzo V; Eguchi S
Clin Sci (Lond); 2014 Jun; 126(11):785-94. PubMed ID: 24329494
[TBL] [Abstract][Full Text] [Related]
5. Cholesterol depletion inhibits epidermal growth factor receptor transactivation by angiotensin II in vascular smooth muscle cells: role of cholesterol-rich microdomains and focal adhesions in angiotensin II signaling.
Ushio-Fukai M; Hilenski L; Santanam N; Becker PL; Ma Y; Griendling KK; Alexander RW
J Biol Chem; 2001 Dec; 276(51):48269-75. PubMed ID: 11585822
[TBL] [Abstract][Full Text] [Related]
6. Caveolin-1 is essential for activation of Rac1 and NAD(P)H oxidase after angiotensin II type 1 receptor stimulation in vascular smooth muscle cells: role in redox signaling and vascular hypertrophy.
Zuo L; Ushio-Fukai M; Ikeda S; Hilenski L; Patrushev N; Alexander RW
Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1824-30. PubMed ID: 15976327
[TBL] [Abstract][Full Text] [Related]
7. cAbl tyrosine kinase mediates reactive oxygen species- and caveolin-dependent AT1 receptor signaling in vascular smooth muscle: role in vascular hypertrophy.
Ushio-Fukai M; Zuo L; Ikeda S; Tojo T; Patrushev NA; Alexander RW
Circ Res; 2005 Oct; 97(8):829-36. PubMed ID: 16151024
[TBL] [Abstract][Full Text] [Related]
8. Independent beta-arrestin2 and Gq/protein kinase Czeta pathways for ERK stimulated by angiotensin type 1A receptors in vascular smooth muscle cells converge on transactivation of the epidermal growth factor receptor.
Kim J; Ahn S; Rajagopal K; Lefkowitz RJ
J Biol Chem; 2009 May; 284(18):11953-62. PubMed ID: 19254952
[TBL] [Abstract][Full Text] [Related]
9. Central role of Gq in the hypertrophic signal transduction of angiotensin II in vascular smooth muscle cells.
Ohtsu H; Higuchi S; Shirai H; Eguchi K; Suzuki H; Hinoki A; Brailoiu E; Eckhart AD; Frank GD; Eguchi S
Endocrinology; 2008 Jul; 149(7):3569-75. PubMed ID: 18356277
[TBL] [Abstract][Full Text] [Related]
10. Urokinase-receptor-mediated phenotypic changes in vascular smooth muscle cells require the involvement of membrane rafts.
Kiyan J; Smith G; Haller H; Dumler I
Biochem J; 2009 Oct; 423(3):343-51. PubMed ID: 19691446
[TBL] [Abstract][Full Text] [Related]
11. Role of epidermal growth factor receptor and endoplasmic reticulum stress in vascular remodeling induced by angiotensin II.
Takayanagi T; Kawai T; Forrester SJ; Obama T; Tsuji T; Fukuda Y; Elliott KJ; Tilley DG; Davisson RL; Park JY; Eguchi S
Hypertension; 2015 Jun; 65(6):1349-55. PubMed ID: 25916723
[TBL] [Abstract][Full Text] [Related]
12. G protein coupling and second messenger generation are indispensable for metalloprotease-dependent, heparin-binding epidermal growth factor shedding through angiotensin II type-1 receptor.
Mifune M; Ohtsu H; Suzuki H; Nakashima H; Brailoiu E; Dun NJ; Frank GD; Inagami T; Higashiyama S; Thomas WG; Eckhart AD; Dempsey PJ; Eguchi S
J Biol Chem; 2005 Jul; 280(28):26592-9. PubMed ID: 15905175
[TBL] [Abstract][Full Text] [Related]
13. Caveolin-1 Deletion Prevents Hypertensive Vascular Remodeling Induced by Angiotensin II.
Forrester SJ; Elliott KJ; Kawai T; Obama T; Boyer MJ; Preston KJ; Yan Z; Eguchi S; Rizzo V
Hypertension; 2017 Jan; 69(1):79-86. PubMed ID: 27895190
[TBL] [Abstract][Full Text] [Related]
14. Microtubules regulate angiotensin II type 1 receptor and Rac1 localization in caveolae/lipid rafts: role in redox signaling.
Zuo L; Ushio-Fukai M; Hilenski LL; Alexander RW
Arterioscler Thromb Vasc Biol; 2004 Jul; 24(7):1223-8. PubMed ID: 15142861
[TBL] [Abstract][Full Text] [Related]
15. Vascular ADAM17 as a Novel Therapeutic Target in Mediating Cardiovascular Hypertrophy and Perivascular Fibrosis Induced by Angiotensin II.
Takayanagi T; Forrester SJ; Kawai T; Obama T; Tsuji T; Elliott KJ; Nuti E; Rossello A; Kwok HF; Scalia R; Rizzo V; Eguchi S
Hypertension; 2016 Oct; 68(4):949-955. PubMed ID: 27480833
[TBL] [Abstract][Full Text] [Related]
16. ADAM17 silencing by adenovirus encoding miRNA-embedded siRNA revealed essential signal transduction by angiotensin II in vascular smooth muscle cells.
Elliott KJ; Bourne AM; Takayanagi T; Takaguri A; Kobayashi T; Eguchi K; Eguchi S
J Mol Cell Cardiol; 2013 Sep; 62():1-7. PubMed ID: 23688779
[TBL] [Abstract][Full Text] [Related]
17. Plasma kallikrein promotes epidermal growth factor receptor transactivation and signaling in vascular smooth muscle through direct activation of protease-activated receptors.
Abdallah RT; Keum JS; El-Shewy HM; Lee MH; Wang B; Gooz M; Luttrell DK; Luttrell LM; Jaffa AA
J Biol Chem; 2010 Nov; 285(45):35206-15. PubMed ID: 20826789
[TBL] [Abstract][Full Text] [Related]
18. Caveolin-1-dependent activation of the metalloprotease TACE/ADAM17 by TGF-β in hepatocytes requires activation of Src and the NADPH oxidase NOX1.
Moreno-Càceres J; Mainez J; Mayoral R; Martín-Sanz P; Egea G; Fabregat I
FEBS J; 2016 Apr; 283(7):1300-10. PubMed ID: 26815118
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin II-induced migration of vascular smooth muscle cells is mediated by p38 mitogen-activated protein kinase-activated c-Src through spleen tyrosine kinase and epidermal growth factor receptor transactivation.
Mugabe BE; Yaghini FA; Song CY; Buharalioglu CK; Waters CM; Malik KU
J Pharmacol Exp Ther; 2010 Jan; 332(1):116-24. PubMed ID: 19797620
[TBL] [Abstract][Full Text] [Related]
20. Characterization of Type 1 Angiotensin II Receptor Activation Induced Dual-Specificity MAPK Phosphatase Gene Expression Changes in Rat Vascular Smooth Muscle Cells.
Gém JB; Kovács KB; Szalai L; Szakadáti G; Porkoláb E; Szalai B; Turu G; Tóth AD; Szekeres M; Hunyady L; Balla A
Cells; 2021 Dec; 10(12):. PubMed ID: 34944046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
